12 Health Care Stocks Moving In Monday's Pre-Market Session

Loading...
Loading...

Gainers

  • Landos Biopharma LABP shares moved upwards by 181.6% to $22.05 during Monday's pre-market session. The market value of their outstanding shares is at $68.7 million. As per the press release, Q4 earnings came out 2 days ago.
  • Altamira Therapeutics CYTO shares rose 49.71% to $2.59. The market value of their outstanding shares is at $4.7 million.
  • Esperion Therapeutics ESPR stock increased by 21.83% to $2.79. The company's market cap stands at $516.2 million.
  • Salarius Pharmaceuticals SLRX shares moved upwards by 21.66% to $0.75. The company's market cap stands at $2.9 million. As per the news, the Q4 earnings report came out yesterday.
  • Neuronetics STIM stock increased by 18.19% to $5.0. The market value of their outstanding shares is at $148.7 million.
  • Nkarta NKTX stock rose 17.93% to $10.52. The market value of their outstanding shares is at $516.2 million. As per the news, the Q4 earnings report came out 2 days ago.

Losers

  • SINTX Techs SINT stock declined by 46.5% to $0.05 during Monday's pre-market session.
  • Akanda AKAN stock declined by 32.2% to $0.17. The market value of their outstanding shares is at $1.4 million.
  • Trxade Health MEDS stock declined by 30.42% to $16.75. The market value of their outstanding shares is at $20.1 million.
  • Nuvation Bio NUVB shares declined by 18.62% to $1.88. The company's market cap stands at $411.8 million.
  • Yield10 Bioscience YTEN stock fell 11.82% to $0.33. The market value of their outstanding shares is at $3.9 million.
  • Virios Therapeutics VIRI stock declined by 9.27% to $0.41. The market value of their outstanding shares is at $7.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...